50
Participants
Start Date
May 1, 2022
Primary Completion Date
March 1, 2027
Study Completion Date
March 1, 2028
Topical infliximab
Infliximab eye drops (10mg/ml) administered four (4) times per day for three (3) months.
No topical infliximab
No treatment with infliximab.
RECRUITING
Centre Hospitalier de l'Université de Montréal, Montreal
Collaborators (1)
Fonds de recherche en ophtalmologie de l'Université de Montréal
OTHER
Maisonneuve-Rosemont Hospital
OTHER
Niagara Health System
OTHER
Prism Eye Institute
OTHER
Ottawa Hospital Research Institute
OTHER
Centre hospitalier de l'Université de Montréal (CHUM)
OTHER